Aspire Biopharma Holdings (ASBP) Net Equity Issued and Repurchased (2024 - 2026)

Aspire Biopharma Holdings (ASBP) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $9.0 million in Q1 2026.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $9.0 million in Q1 2026; TTM through Mar 2026 was $9.0 million, a N/A change from a year earlier, with the FY2024 full-year figure at $2.5 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased for Q1 2026 stood at $9.0 million, up from $28561.0 in the prior quarter.
• Over the last five years, Net Equity Issued and Repurchased for ASBP reached as high as $9.0 million in Q1 2026 and fell as low as $28561.0 in Q2 2024.